These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11288242)

  • 1. [Comparative efficacy of low molecular heparin (fraxiparine), non-fractionized heparin and anti-aggregate therapy in the prophylaxis complex for thromboembolic complications after surgical interventions performed for oncological disease].
    Malanov VA; Nechvidova EA; Fomina SA
    Klin Khir; 2000 May; (5):35-8. PubMed ID: 11288242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
    Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
    Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylaxis of thromboembolic complications in bariatric surgery].
    Lavrik AS; Tyvonchuk AS; Bubalo AF; Zgonnik AIu
    Klin Khir; 2007 Aug; (8):39-42. PubMed ID: 18318070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of thromboembolic complications in patients, operated on for alimentary-constitutional obesity].
    Grubnik VV; Golliak VP; Grubnik AV
    Klin Khir; 2006 Sep; (9):35-9. PubMed ID: 17269389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low molecular weight heparin thromboprophylaxis on bleeding complications after gastric cancer surgery.
    Jeong O; Ryu SY; Park YK; Kim YJ
    Ann Surg Oncol; 2010 Sep; 17(9):2363-9. PubMed ID: 20358302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
    Welzel D; Wolf H; Koppenhagen K
    Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
    Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
    Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of LMW heparin in the prevention of thromboembolic disease in surgical patients: a controlled comparison with nonfractionated heparin].
    Salcuni P; Azzarone M
    Boll Chim Farm; 1987 Dec; 126(12):2S-7S. PubMed ID: 2843203
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of thromboembolism in patients undergoing colorectal surgery.
    McLeod RS
    Drugs; 1996; 52 Suppl 7():38-41. PubMed ID: 9042558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low molecular weight heparins. Implications in anesthesia and resuscitation].
    Llau JV; Hoyas L; Ezpeleta J; García-Polit J; Barberá M; Santes MJ
    Rev Esp Anestesiol Reanim; 1997 Feb; 44(2):70-8. PubMed ID: 9148359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thromboembolic complications in laparoscopic surgery and their prophylaxis].
    Nichitaĭlo ME; Beliaev VV
    Klin Khir; 2003 Jul; (7):20-4. PubMed ID: 12953422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparins: the future of thromboembolic therapy.
    Dobbin KR
    Nurse Pract; 1998 Mar; 23(3):98,101-4,106-7. PubMed ID: 9560832
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboembolic prophylaxis with low-molecular-weight heparin in patients with blunt solid abdominal organ injuries undergoing nonoperative management: current practice and outcomes.
    Eberle BM; Schnüriger B; Inaba K; Cestero R; Kobayashi L; Barmparas G; Oliver M; Demetriades D
    J Trauma; 2011 Jan; 70(1):141-6; discussion 147. PubMed ID: 21217492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non controlled prospective study of the efficacy and tolerance of a low molecular weight heparin].
    Wattrisse G; Lecoutre D; Groux-Pante C
    J Mal Vasc; 1991; 16(4):367-71. PubMed ID: 1665169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
    Harenberg J; Piazolo L; Misselwitz F
    Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.